Elanco

Elanco

Elanco | Solutions for Protecting and Enhancing Animal Health.

Launch date
Employees
Market cap
AUD11.1b
Enterprise valuation
AUD19.2b (Public information from Sep 2024)
Greenfield Massachusetts (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues3.3b4.8b4.4b4.4b4.4b4.6b4.8b
% growth7 %46 %(7 %)--3 %5 %
EBITDA461m853m886m945m918m1.0b1.1b
% EBITDA margin14 %18 %20 %21 %21 %22 %23 %
Profit(560m)(472m)(74.0m)(1.2b)334m135m226m
% profit margin(17 %)(10 %)(2 %)(28 %)8 %3 %5 %
EV / revenue6.1x4.0x2.6x2.9x2.8x2.6x2.3x
EV / EBITDA43.6x22.4x12.8x13.5x13.2x11.7x10.3x
R&D budget327m369m321m327m---
R&D % of revenue10 %8 %7 %7 %---
  • Edit
DateInvestorsAmountRound
N/A

$2.9m

Grant
N/A

N/A

IPO
*

$250m

Post IPO Equity
Total FundingAUD4.5m

Recent News about Elanco

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
  • Edit
Kindred Biosciences
ACQUISITION by Elanco Aug 2021
Aratana Therapeutics
ACQUISITION by Elanco Jul 2019
Vetoquinol
ACQUISITION by Elanco Feb 2020
Prevtec microbia
ACQUISITION by Elanco Aug 2019
Bayer Animal Health
ACQUISITION by Elanco Aug 2019